APA (7th ed.) Citation

Kuykendall, A., Kremyanskaya, M., Ginsburg, Y., Pemmaraju, N., Ritchie, E., Gotlib, J., . . . Verstovsek, S. (2022, June). P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA. HemaSphere.

Chicago Style (17th ed.) Citation

Kuykendall, A., et al. "P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA." HemaSphere Jun. 2022.

MLA (9th ed.) Citation

Kuykendall, A., et al. "P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA." HemaSphere, Jun. 2022.